Want to join the conversation?
JPMorgan analyst Stephen Tusa asks $HON to talk about the moving parts in ACS in 2H16, and some color on the back-end loaded trajectory. CEO David Cote says that ACS in 3Q16 will be flat to up 1% & for 4Q16, it will be down 1% to flat. The company said that it will get some improvement in S&PS, particularly in 4Q16, to help get some growth there.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.